Ebitda 16% above guidance, operating cash flow 30% above guidance! And this is before white label benefits! Well done all!
- Forums
- ASX - By Stock
- FND
- Ann: FND FY24 Results Presentation
Ann: FND FY24 Results Presentation, page-2
-
-
- There are more pages in this discussion • 126 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add FND (ASX) to my watchlist
|
|||||
Last
$4.68 |
Change
0.030(0.65%) |
Mkt cap ! $228.8M |
Open | High | Low | Value | Volume |
$4.62 | $4.76 | $4.60 | $488.4K | 104.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 3998 | $4.67 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$4.72 | 4521 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 500 | 4.700 |
1 | 2 | 4.690 |
1 | 40 | 4.680 |
1 | 450 | 4.670 |
1 | 650 | 4.660 |
Price($) | Vol. | No. |
---|---|---|
4.720 | 3980 | 7 |
4.730 | 566 | 3 |
4.740 | 260 | 3 |
4.750 | 1994 | 2 |
4.760 | 3650 | 2 |
Last trade - 14.52pm 03/07/2024 (20 minute delay) ? |
Featured News
FND (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online